Research on depression and its treatment. Covers stress-response biology, ketamine and dopamine-targeting therapies, treatment-resistant cases, and brain mechanisms.
Research reveals bidirectional relationships between higher BMI and financial difficulties, loneliness and stress. Higher BMI may lead to stigma, social isolation and healthcare costs, while financial strain can limit access to healthy food and physical activity.
A new study finds that individuals with higher resilience tend to place greater weight on positive aspects in cost-benefit decisions, a process mediated by brain activity. This regulated handling of negative information is linked to increased acceptance and improved psychological resilience.
Researchers found that people with depression experience reduced desire for food rewards during anticipation, but not during consumption. The study suggests that anhedonia in depression is characterized by altered expectation and motivational processes, which may be targeted in therapeutic approaches.
Researchers found that individuals with stronger brain responses to negative information were more resilient in their thoughts and feelings. They accepted more offers with mixed consequences, indicating a lower value on negative outcomes. This study suggests that controlling negative thoughts may enable people to build mental resilience.
A study links insulin resistance and leptin dysregulation to cognitive impairment in bipolar disorder, highlighting the potential of targeted clinical pathways. Metabolic alterations are associated with cognitive deficits and poorer performance in memory and attention.
Researchers discovered that genes linked to neuronal communication are also altered in immune cells of patients with depression, reinforcing the systemic nature of the disease. This finding paves the way for developing blood tests to identify and diagnose depression, as well as new treatment approaches targeting inflammation.
A study by UPF found that AI-generated images of depression reinforce stereotypes and stigmas, particularly in terms of marginalization and social exclusion. The research highlights the need for responsible mental health communication, emphasizing the importance of considering diverse experiences and promoting transparency around AI use.
A digital therapy app was found to be more effective in treating anxiety disorders, depression, and eating disorders among college students compared to traditional campus clinics. The study, which tested the app's effectiveness over six months, showed a significant increase in symptom-free students and services uptake.
Researchers at UCLA Health have discovered that transcranial magnetic stimulation (TMS) selectively targets specific brain cells to restore communication channels in the brains of stressed mice. The study found that TMS repairs damaged dendritic spines, leading to enhanced activity and rapid improvements in stress-related behaviors.
A Charité study analyzed therapist experiences worldwide to create a profile for successful psychedelic-assisted therapy. Key characteristics include stable environment, support from loved ones, and specific personality traits that contribute to treatment success.
A randomized clinical trial found that genotype-guided prescribing of SSRIs did not improve depression symptoms at 3 months but showed higher remission rates at 6 months. Future studies should focus on the long-term impact of this approach.
This systematic review and meta-analysis found differences in efficacy and acceptability of adjunctive atypical antipsychotics for major depressive disorder. The study highlights the need for more well-controlled studies on maintenance efficacy of these medications.
A systematic review and meta-analysis found single and repeated intravenous ketamine infusions to be efficacious in reducing suicidal and depressive symptoms in acute major depressive episodes. Longer-term outcomes remain unclear.
A new study with over 3,700 UK participants found that better cognitive functioning may be associated with a higher risk of future depressive episodes in those with a history of depression. In contrast, worse cognitive performance was linked to a lower risk of relapse in both individuals with previous depression and control participants.
Researchers found that psilocybin causes temporary shifts in brain entropy, leading to increased insight and emotional self-awareness. This correlates with improved well-being and cognitive flexibility, suggesting the psychedelic trip is key to its therapeutic effects.
Researchers developed a framework to study the impact of genetic variants on neurodevelopmental disorders. By analyzing induced pluripotent stem cells, they found that genetic background can lead to different clinical outcomes in individuals with the same deletion on chromosome 16.
Researchers found that accelerated biological aging of a type of white blood cell called monocytes is linked to cognitive and mood-related symptoms of depression. This discovery could lead to earlier diagnosis and personalized treatment for depression, particularly in high-risk populations such as women with HIV.
Researchers identified a specific subset of opioid receptors on interneurons in the prefrontal cortex that ketamine targets to relieve depressive symptoms. Combining small doses of three drugs targeting the same pathway may provide an effective alternative to ketamine with fewer side effects.
A study by SWPS University found that people with depressive symptoms use less active language, such as 'I am incapable' instead of 'I achieve goals'. This analysis of social media posts shows promise for early detection and prevention of depression.
A nationwide ecological study found a statistical correlation between fewer psychiatric beds and higher suicide rates in Sweden. The study suggests that investing in outpatient care may not be enough to prevent suicides, highlighting the need for further research into healthcare resource allocation.
Dampening, a phenomenon where positive emotions are diminished, can undermine well-being over time. Research found that future-focused thoughts, such as 'positive feelings won't last,' are strong predictors of depressive symptoms.
Motif Neurotech has received FDA approval to begin the first clinical trial of its therapeutic BCI device, DOT, for treatment-resistant depression. The study will test the device's effectiveness in delivering electrical stimulation to brain circuits linked to depression.
Researchers at Rutgers University tested the efficacy of Bright IDEAS, a problem-solving skills training intervention, in reducing depression and anxiety symptoms and improving health-related quality of life among young adults with cancer. The study found significant reductions in symptoms and improvements in quality of life compared t...
New research suggests exposure to fathers' depression in pre-adolescence is associated with poor educational outcomes among males, but not females. Early identification and family-centered support can help promote school success and long-term well-being for affected sons.
A study published in Scientific Reports reveals a connection between ADHD-related traits and chronic pain, highlighting the importance of addressing ADHD in pain management. The research suggests that treating ADHD may help reduce chronic pain severity.
A new study reveals that electroconvulsive therapy (ECT) can lead to significant negative impacts on standard of living, personal relationships, and even brain damage. Relatives and friends of ECT patients report long-term effects including memory loss, emotional blunting, and loss of independence.
A recent study estimates that 2.8% of US residents over 12 used psilocybin in the past year, highlighting the need for clinicians to be aware of its use among patients with depression. The findings also underscore the importance of longitudinal studies and increased public health surveillance as de-criminalization efforts progress.
A USC-led team is working on a medical device that uses tears to monitor health, starting with dry eye disease. The device aims to provide continuous monitoring and automated medication delivery, improving patient comfort and treatment efficacy.
tACS modulates brain oscillations, induces synaptic plasticity, and regulates neurotransmitter release to alleviate symptoms of various neuropsychiatric conditions. Personalized approaches are essential for treatment efficacy.
A study published in the Journal of Aggression, Maltreatment & Trauma found that feeling safe with a trusted adult during childhood reduces the risk of depression, chronic disease, and poor health. The presence of protective adults significantly mitigates the long-term impact of abuse.
Research found that gender-diverse teens reported higher rates of psychological stress and psychotic-like experiences, which can lead to depression, anxiety, and other serious mental health disorders. Bullying and unsupportive legislation drove these findings.
A recent study found that academic burnout is associated with increased internet gaming and depression in Chinese adolescents. The study highlights the importance of targeted prevention strategies, including mental health check-ups, counseling sessions, stress management programs, and attentional bias modification training.
A study found divergent neural pathways for drinking patterns in young men and women, highlighting the importance of sex-specific prevention strategies. Amygdala reactivity was associated with depressive symptoms in males, while females showed a 'threat-avoidance' profile with lower alcohol risk scores.
A new study from the University of Southern Denmark finds that people with depression experience significant income loss, with losses averaging 17% lower than those without depression. Income loss persists and grows over time, even after diagnosis.
A Vanderbilt University study analyzed 633,000 survey participants and found that loneliness played a critical role in suicidal ideation. Reducing loneliness could
A randomized trial tested HabitWorks, a smartphone app offering personalized exercises to target interpretation bias. Participants reported significant improvements in interpretation bias, functioning, and overall mental health symptom severity.
Researchers are testing whether SAINT, a non-invasive brain stimulation therapy, can quickly relieve symptoms of postpartum depression. The study aims to find faster and more effective treatments for women experiencing depression after childbirth.
A study published in Brain Medicine suggests autonomic dysfunction, particularly parasympathetic and sympathetic imbalances, contributes to depressive symptoms in patients unresponsive to conventional antidepressants. Low-dose medications targeting these imbalances may offer a new approach to treatment.
A higher testosterone level does not always indicate well-being in men, according to a study at the University of Gothenburg. Muscle health and inflammation are linked to testosterone levels, but symptoms like fatigue and depression have weaker connections.
The new joint department combines expertise in medical devices, neuroengineering, imaging science, and more to advance biomedical research and translate discoveries into meaningful health advances. The partnership aims to accelerate the translation of discoveries into improvements in human health.
Researchers identified NOX-1 as a key molecular target to prolong ketamine's therapeutic benefits. Combining ketamine with NOX-1 inhibitors significantly extended its antidepressant-like effects. K-4, a novel AMPAR modulator, also showed rapid antidepressant effects that persisted for at least 2 weeks.
A recent study published in Gait & Posture found that analyzing a person's walk and getting up from a chair can identify elevated depression and anxiety symptoms. The researchers used machine-learning models trained on data from participants' movements combined with information about their mental state, achieving high accuracy rates.
A study estimated income losses from individual perspectives in Denmark from 2000 to 2023 after hospital diagnoses of depression, alcohol use disorder, stroke, and breast cancer. The researchers found that income losses were largest for mental disorders, with average losses growing over time, particularly among younger individuals.
Researchers found that GH001 significantly improved depression symptoms in patients with treatment-resistant depression, outperforming placebo. The treatment was well-tolerated and suggests a potential novel treatment option.
A new BGU study examines the emotional labor of teachers during wartime, revealing that those who fake emotions are at higher risk of psychological collapse. The research emphasizes the importance of fostering internal motivation and clear educational identities to mitigate teacher attrition.
A new approach allows oral delivery of drugs previously requiring injection by piggybacking on natural fat absorption pathways. The medication, GlyphAllo, bypasses the liver's security checkpoint and is absorbed through the gut's lymphatic system, allowing it to enter the bloodstream directly.
Researchers are using preclinical mouse models and patient studies to identify cellular and circuit-level mechanisms driving mood-state transitions. The goal is to develop new treatments by rescuing dysfunctional brain circuits in depression.
A new study published in JAMA Network Open reveals that fathers' mental health declines over time after the birth of their child, with increased risk of anxiety and substance abuse diagnoses returning to pre-pregnancy levels. However, depression and stress-related disorders continue to rise by over 30% one year after childbirth.
A study found that inflammation markers may signal depression in women with type 2 diabetes, but vary based on depression symptoms and measures. The research suggests a path toward precision mental health by identifying specific inflammatory biomarkers linked to different dimensions of mental health.
A systematic review of social media platforms reveals that TikTok contains a substantial proportion of misleading information about mental health and neurodivergence, with higher rates of misinformation than other platforms. The study emphasizes the importance of credible sources and evidence-based content to combat spreading false ide...
Researchers from SWPS University develop Post-Game Depression Scale (P-GDS) to capture players' experiences after finishing video games. The study reveals RPG fans are most at risk of intense P-GD, associated with stronger depressive symptoms and lower well-being.
Research suggests that persistent pain drives progressive changes in the hippocampus, a brain region involved in emotional regulation. This can shape whether people develop depression or remain emotionally resilient. The study's findings challenge the idea that depression is an inevitable consequence of long-term pain.
A concerning rise in adolescent obesity has been found, with overall rates climbing to 15.9% in 2023. Obesity patterns also reveal a decline in weight-loss attempts, with females more likely to attempt weight loss but fewer adolescents reporting efforts in 2023.
A cohort study found that adverse childhood experiences (ACEs) were associated with an increased risk of treatment-resistant depression in adults. Preventing ACEs and incorporating ACE history into clinical assessment may help identify individuals at elevated risk for treatment resistance.
A new study finds that widowed men experience poorer physical and mental health, while widowed women show resilience and improved well-being after losing their spouse. The study highlights the need for gender-specific strategies to support recovery after spousal loss.
A UK study found that a 12-week ketogenic metabolic therapy program led to significant reductions in depression and anxiety scores. The program, delivered remotely, showed a 62% reduction in depression symptoms and a 46% reduction in anxiety, with 100% of participants completing the program.
Emerging research across conceptual frameworks, biomarker science, digital phenotyping, and artificial intelligence synthesizes a translational pathway toward a more biologically grounded and clinically useful approach to psychiatric diagnosis. The current system falls short due to standardized clinical language and lack of biological ...
A new study models brain aging and resilience over the lifespan, uncovering individual factors that affect cognition and identifying potential biomarkers of healthy brain aging. Researchers are now incorporating diverse data, including social and lifestyle factors, to create a broader picture of the aging brain.
A new PET imaging study reveals that ketamine relieves treatment-resistant depression by altering AMPAR in brain regions, providing potential biomarker for personalized treatment. The study found that ketamine increased AMPAR density in several cortical regions and decreased it in reward-related areas, strongly correlating with reducti...
Researchers analyzed data from over 62,000 participants, finding that loneliness partially mediated the link between anxiety and suicidal thoughts as well as depressive symptoms and suicidal ideation. Targeting loneliness may be a crucial strategy to prevent progression from these conditions.